Management of anemia in patients with chronic kidney disease.
The prevalence of chronic kidney disease (CKD) is increasing at an alarming rate in the United States and other Western countries, due in part to an increased incidence of diabetes, which itself appears to be a direct consequence of the obesity epidemic in modern society. Hypertension, a condition that also results from or is exacerbated by excess body weight, remains an important cause of CKD as well. In patients with CKD, anemia is both a common occurrence and a significant risk factor for increased morbidity and mortality, especially from cardiac complications such as coronary heart disease, cerebrovascular disease, peripheral vascular disease, and congestive heart failure. Correction of anemia in patients with CKD is associated with demonstrated benefits, including a reduction in hospitalization and per-patient healthcare expenditures. In this article, Dr Wish describes the magnitude of the population with, or at risk for, CKD in the United States and examines data on the risks associated with anemia, particularly in patients with comorbid conditions such as diabetes and heart disease. Practical issues related to the treatment of anemia in patients with CKD are also presented.
Wish
Jay B
JB
Case Western Reserve University, School of Medicine, Cleveland, OH 44106, USA. jbw2@po.cwru.edu
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000150:complications; D005260:Female; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D018487:Ventricular Dysfunction, Left / Q000209:etiology / Q000517:prevention & control
D006397:Hematinics